Back
ESC Premium Access

Estimation of fractional flow reserve in patients with intermediate coronary artery disease; usefulness of estimated fractional flow reserve value by using clinical and angiographic factors

Session: Poster Session 4 - Coronary artery disease : diagnosis pharmacotherapy and revascularisation
Topic: Angiography, Invasive Imaging
Speaker: Doctor H. Watanabe (Osaka, JP)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Heitaro Watanabe

Kinki University, Osaka (Japan)
0 follower

19 more presentations in this session

Prevalence of thin-cap fibroatheroma in relation to the physiological stenosis severity determined by fractional flow reserve and instantaneous wave-free ratio

Speaker: Doctor M. Hoshino (Amsterdam, NL)

Access
Abstract
Slides
Like
Thumbnail

Evaluating the 10-year survival after an FFR-guided strategy in patients with proximal isolated stenosis in the left anterior descending coronary artery: impact of control selection

Speaker: Professor M. Kavousi (Rotterdam, NL)

Access
Abstract
Like
Thumbnail

Plaque erosion and calcium nodule associated thrombus in non-ischemic lesions of diabetic patients

Speaker: Doctor T. Roleder (Wroclaw, PL)

Access
Abstract
Like
Thumbnail

In-vivo correlation of near-infrared spectroscopy lipid content and optical coherence tomography minimal cap thickness

Speaker: Doctor C. Zanchin (Bern, CH)

Access
Abstract
Slides
Like
Thumbnail

High aortic stiffness and myocardial ischemia in non-obstructive coronary artery disease (the MicroCAD project)

Speaker: Professor M. Lonnebakken (Bergen, NO)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 4 - Coronary artery disease : diagnosis pharmacotherapy and revascularisation

Speakers: Doctor H. Watanabe, Doctor M. Hoshino, Professor M. Kavousi, Doctor T. Roleder, Doctor C. Zanchin...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources